TL;DR
This study introduces and validates Quantitative Flow Ratio (QFR), an angiography-based method for assessing coronary artery stenosis, as a faster and more accurate alternative to traditional pressure-wire-derived Fractional Flow Reserve (FFR). QFR demonstrated superior diagnostic performance and significantly reduced procedure time, paving the way for broader adoption of physiological lesion assessment in interventional cardiology.
What Problem Does This Paper Address?
Physiological assessment of coronary artery lesions, primarily through Fractional Flow Reserve (FFR), is crucial for guiding percutaneous coronary interventions (PCI). However, the adoption of FFR remains low globally due to factors like the cost and complexity of pressure wires, the need for pharmacological hyperemia induction, and the time required for measurement. This limits the widespread use of evidence-based, physiology-guided PCI. The paper addresses this by evaluating Quantitative Flow Ratio (QFR), a novel method that derives FFR from 3D angiographic reconstructions and contrast flow velocity estimates, aiming to provide a more accessible and efficient alternative.
Methods
The study employed a prospective, observational, multicenter design (FAVOR II Europe-Japan) involving 11 international centers. Patients with stable angina pectoris were enrolled. For each eligible lesion, both in-procedure QFR and pressure-wire-derived FFR were measured. Additionally, a core lab performed 2D quantitative coronary angiography (2D-QCA) analysis. The primary comparison focused on the sensitivity and specificity of QFR versus 2D-QCA in identifying hemodynamically significant lesions, using FFR as the gold standard. QFR was computed using CE-marked software (QAngio XA-3D/QFR solution) based on 3D vessel reconstructions and contrast flow velocity estimates. FFR measurements followed current guidelines, utilizing pressure wires and adenosine for hyperemia.
Datasets
The study enrolled 329 patients, with paired assessment of FFR, QFR, and 2D-QCA available for 317 lesions. This dataset served as the basis for evaluating QFR's diagnostic performance. No new benchmark datasets were introduced; rather, existing clinical data from participating centers were utilized.
Key Insights and Ideas
- QFR as a Viable Alternative: The study strongly supports QFR as a clinically feasible and accurate method for assessing coronary stenosis, directly challenging the necessity of pressure wires in many cases.
- Speed Advantage: The significantly shorter time required for QFR computation compared to FFR is a major practical advantage, potentially streamlining cath lab workflow.
- Superior Diagnostic Performance: QFR outperformed traditional 2D-QCA in both sensitivity and specificity for detecting functionally significant lesions, bringing it closer to the diagnostic accuracy of FFR.
- Broadening Access: By eliminating the need for pressure wires and pharmacological hyperemia, QFR has the potential to democratize physiological lesion assessment, making it accessible to more centers and patients.
Key Results
- Diagnostic Accuracy: QFR demonstrated significantly higher sensitivity (86.5%) and specificity (88.9%) compared to 2D-QCA (44.2% and 76.5%, respectively) when using FFR ≤0.80 as the reference standard (P<0.001 for sensitivity, P=0.002 for specificity).
- Area Under the Curve (AUC): QFR had a significantly higher AUC (0.92) compared to 2D-QCA (0.64) for per-vessel diagnostic performance (P<0.001).
- Procedure Time: The median time to complete QFR (5.0 minutes) was significantly shorter than the median time to complete FFR (7.0 minutes) (P<0.001).
- Correlation and Agreement: QFR showed good per-vessel correlation (r=0.83) and agreement with FFR, with a mean difference of 0.01±0.06.
Limitations and Future Work
- Study Population: The study primarily included patients with stable angina pectoris, and the diagnostic precision of QFR in non-culprit lesions after myocardial infarction was not confirmed.
- Lesion Complexity: Lesions with Medina type 1.1.1 and 1.0.1 bifurcations were excluded due to limitations of the current QFR application, indicating a need for further development in this area.
- FFR-Pullbacks: The study did not mandate FFR-pullbacks during adenosine infusion, limiting direct comparison with spatially sensitive, continuous QFR values.
- Microvascular Dysfunction: The study could not further characterize lesion physiology in the presence of microvascular dysfunction, as FFR was the sole gold standard.
- Angiographic Acquisition Time: The time to QFR did not include the time for angiographic acquisition, which could vary and potentially impact the overall time savings.
- Future Work: Randomized trials are needed to confirm that QFR provides noninferior clinical outcomes compared to FFR-based assessment of intermediate coronary stenosis. Further development is also required for QFR analysis in complex lesion subsets like bifurcations.
Summary updated